Policy / Regulatory

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented
GQCE testing

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented

China's National Medical Products Administration (NMPA) released the 109th Catalog of Reference Listed Drugs for Chemical Generic Drugs, adding 30 new product specifications and supplementing information for 24 product specifications…

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

China's NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

China’s NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
FDA Launches Commissioner’s National Priority Voucher Program for Accelerated Drug Reviews
Priority reviews

FDA Launches Commissioner’s National Priority Voucher Program for Accelerated Drug Reviews

China's NHC Unveils 2025 Healthcare Reforms to Tackle Procurement and Service Irregularities
NHC (NHFPC)

China’s NHC Unveils 2025 Healthcare Reforms to Tackle Procurement and Service Irregularities

NMPA Issues Immediate Guidelines for NGS-Related IVD Reagent Classification
NMPA

NMPA Issues Immediate Guidelines for NGS-Related IVD Reagent Classification

China Updates Class 3 Hospital Accreditation Standards for 2025
NHC (NHFPC)

China Updates Class 3 Hospital Accreditation Standards for 2025

Show More